Highest-materiality recent filing
Kyndryl Q1 FY2027: net loss $55M vs prior-year net income $56M; reaffirms FY outlook
Revenue $3.6B, down 3% YoY; pretax loss $69M vs pretax income $92M a year ago.
Kyndryl names Ellen Johnson CFO (effective Aug 6) and Andrew Bonzani General Counsel
Ellen Johnson appointed CFO, effective Aug 6, 2026; joins from IPG where she was EVP & CFO from 2020-2025.
Kyndryl reports FY2026 results and $200M workforce rebalancing; FY2027 adj pretax guidance $600-700M
FY2026 revenue $15.1B flat YoY; net income $198M ($0.85 diluted); adjusted EPS $1.46.
Kyndryl names Harsh Chugh Interim CFO and Mark Ringes Interim General Counsel
Harsh Chugh appointed Interim CFO effective Feb 5, 2026; he previously served as COO and Global Head of Practices.
Net income $57M ($0.25 diluted EPS) vs $215M ($0.89) a year ago; adjusted net income $122M ($0.52).
Kyndryl Q2 FY2026 net income $68M, adjusted EPS $0.38; adds $400M buyback
Revenue $3.7B, down 1% YoY; constant-currency revenue down 3.7%.
Revenue $3.74B, -2.6% constant currency; net income $56M vs $11M prior year; pretax income $92M (+44%).
Kyndryl Q4 net income $68M, adjusted EPS $0.52; record FY signings $18.2B, FY2026 guide
Q4 revenue $3.8B (-1% reported, +1.3% CC); net income $68M ($0.28 diluted) vs net loss of $45M a year ago.
Kyndryl Q3 FY2025: net income $215M ($0.89 EPS) vs loss YoY; raises FY2025 outlook
Revenue $3.74B (-3% constant currency); adjusted pretax income $160M (+154% YoY).
Kyndryl authorizes $300 million share repurchase program
$300 million share repurchase program authorized by board.
Kyndryl reports Q2 FY2025 revenue $3.8B, net loss $43M; adjusted EBITDA $557M, reaffirms FY outlook
Revenue $3.8B, down 7% YoY; pretax loss $5M, net loss $43M ($0.19/diluted share).
Kyndryl Q1 net income $11M vs prior-year loss; raises FY adjusted earnings outlook
Revenues $3.74B, down 11% YoY (8% constant currency); pretax income $64M vs loss $141M prior year.
Kyndryl Q4 net loss $45M, adj. pretax income $30M; FY2025 adj. pretax income target at least $435M
Q4 revenue $3.8B (-10% YoY); FY revenue $16.1B (-6% YoY) due to reducing low-margin content.
Revenue $3.9B, down 9% YoY (10% constant currency); net loss $12M ($0.05 loss per diluted share), improved from $106M loss YoY.
Kyndryl Q2 FY2024: adjusted EBITDA +34%; raises pretax income guidance to ≥$140M
Revenue $4.1B (-3% YoY); net loss $142M ($0.62/sh) vs $281M loss prior year.
Kyndryl Q1 FY2024: rev $4.2B, adj. EBITDA $612M (+25% YoY), raises FY EBITDA margin outlook to ~14%
Revenues $4.2B, down 2% YoY; net loss $141M ($0.62 loss per diluted share).
Kyndryl reports Q4 net loss $737M, FY23 revenue $17.0B; guides FY24 margin expansion
Q4 revenue $4.3B (-4% YoY, +1% cc); net loss $737M vs $229M loss prior year.
Kyndryl Q3 revenue $4.3B, net loss $106M; raises FY revenue outlook
Revenue $4.3B, down 6% YoY but up 3% constant currency; net loss $106M ($0.47/diluted), improved from $731M loss a year ago.
Kyndryl Q2 FY2023 revenue $4.2B, net loss $281M; updates FY outlook
Revenue $4.2B, down 9% YoY, up 1% constant currency; net loss $281M vs $690M loss prior year.
Kyndryl Q1 FY2023 revenue $4.3B, net loss $250M, reaffirms FY guidance with currency hit
Revenue $4.3B (-10% YoY; -3% constant currency); net loss $250M ($1.11 diluted EPS loss); adjusted pretax loss $50M.
Stockholders approved LTPP amendment increasing share issuable by 8.5M shares and changing governing law to NY.
Kyndryl discloses potential indemnity exposure from $1.434B BMC judgment against IBM
Texas court awarded BMC $717M in direct damages and $717M in punitive damages plus interest against IBM.
Kyndryl Q1 net loss $229M, rev $4.4B (-7% YoY); signings up 27% cc
Revenues $4.4B, down 7% YoY (3% cc); net loss $229M ($1.02 diluted EPS).
Kyndryl reports Q4 net loss $740M, FY2021 net loss $2.3B; revenue down 8% YoY
Q4 revenue $4.6B, down 8% YoY; pretax loss $732M includes $469M goodwill impairment.
Kyndryl adopts Annual Incentive Plan, sets exec cash bonus targets, amends severance plan
Target cash bonus for transition period (Jan-Mar 2022): 200% of base salary for CEO Schroeter and Group President Keinan; 125% for CFO Wyshner, GC Sebold, CHRO Charbonnier.
Kyndryl Q3 revenue falls 6% to $4.58B, net loss widens to $692M; Microsoft partnership
GAAP net loss of $692M vs loss of $238M a year ago; adjusted EBITDA margin improved to 15.8% from 14.8%.
Kyndryl completes IBM spin-off; draws $500M term loan; appoints board & CEO
Spin-off completed Nov 3, 2021; IBM distributed 1 Kyndryl share per 5 IBM shares held.
Kyndryl enters $3.65B in credit facilities (revolver and term loan) post-IBM separation
$3.15B five-year revolving credit facility and $500M three-year term loan entered on Oct 18, 2021.
Kyndryl issues $2.35B of senior notes in four tranches; IBM guaranty to be released at separation
Issued $700M 2.050% notes due 2026, $500M 2.700% due 2028, $650M 3.150% due 2031, $550M 4.100% due 2041.
On July 1, 2026, the Board of Directors (the “Board”) of Kyndryl Holdings, Inc. (the “Company”) appointed Ellen Johnson as Chief Financial Officer of the Company, effective the day after the Company files its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Effective Date”).
Additionally, on July 1, 2026, the Board appointed Andrew Bonzani as General Counsel and Secretary of the Company, effective immediately.
on or prior to November 3, 2021, the persons set forth in the table below assumed their positions as directors on the Company’s Board of Directors (our “Board”).
on or prior to November 3, 2021, the persons set forth in the table below assumed their positions as directors on the Company’s Board of Directors (our “Board”).
As previously reported in the Information Statement, effective on November 3, 2021, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person’s name:
on or prior to November 3, 2021, the persons set forth in the table below assumed their positions as directors on the Company’s Board of Directors (our “Board”).
on or prior to November 3, 2021, the persons set forth in the table below assumed their positions as directors on the Company’s Board of Directors (our “Board”).
As previously reported in the Information Statement, effective on November 3, 2021, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person’s name:
As previously reported in the Information Statement, effective on November 3, 2021, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person’s name:
As previously reported in the Information Statement, effective on November 3, 2021, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person’s name:
on or prior to November 3, 2021, the persons set forth in the table below assumed their positions as directors on the Company’s Board of Directors (our “Board”).
As previously reported in the Information Statement, effective on November 3, 2021, the following persons were appointed as executive officers of the Company serving in the offices of the Company set forth beside each person’s name:
Max materiality 0.90 · Median 0.70 · Most common event earnings